The 20 Best Hereditary Neuroblastoma Doctors Near Me in Bronx, NY

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Antonio Fojo is an Internal Medicine provider practicing medicine in New York, New York. Dr. Fojo is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma. Dr. Fojo is currently accepting new patients.

Gastro-Intestinal Cancer. Dr. Kaubisch is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Ampullary Cancer.

Tarek Elrafei is an Oncologist practicing medicine in Bronx, New York. Dr. Elrafei is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Breast Cancer, Bone Marrow Aspiration, and Thrombectomy.

I am a pediatric oncologist who specializes in caring for children with solid tumors, especially neuroblastoma, Wilms' and other kidney tumors, and liver tumors such hepatoblastoma and hepatocellular carcinoma. I serve as chief of the Division of Hematology, Oncology and Stem Cell Transplantation at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital.I treat children of all ages, from infants to young adults. Some of the cancers I treat are rare (liver tumors account for one to two percent of childhood cancers), but they can be very complex and require a multidisciplinary approach so patients have the best outcomes. I enjoy working as part of a team of physicians, nurse practitioners, nurses, social workers, child life specialists, and other dedicated professionals who care deeply about our patients and provide care with compassion and comfort.I also conduct basic science research. The latest advances in tumor genetics and the design of innovative therapies make this a very exciting time for cancer research. My team and I have done extensive research on the genetics of hepatoblastoma. We have developed mouse models of this disease and are entering a new phase where we are offering a personalized/precision medicine approach to children with this disease. We are also identifying novel genes that specifically target neuroblastoma—information that may be used to create targeted therapies. Dr. Yamashiro is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Hepatoblastoma. Dr. Yamashiro is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Yamashiro is currently accepting new patients.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His clinical expertise encompasses Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Garvin is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Garvin is currently accepting new patients.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kahn is currently accepting new patients.

Susan Bates is an Internal Medicine specialist and an Oncologist practicing medicine in New York, New York. Dr. Bates is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, T-Cell Lymphoma, Pancreatic Ductal Adenocarcinoma, and Cutaneous T-Cell Lymphoma (CTCL). Dr. Bates is board certified in Internal Medicine and Medical Oncology. Dr. Bates is currently accepting new patients.

Jovana Pavisic is a Pediatrics provider practicing medicine in New York, New York. Dr. Pavisic is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Hepatoblastoma, and Acute Lymphoblastic Leukemia (ALL). Dr. Pavisic is board certified in Pediatrics and Pediatric Hematology-Oncology.

Myra Davila is a primary care provider, practicing in Geriatrics in Bronx, New York. Dr. Davila is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Ascariasis.

Nobuko Hijiya is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Hijiya is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, L1 Syndrome, and Bone Marrow Transplant. Dr. Hijiya is currently accepting new patients.

Diane George is a Pediatrics provider practicing medicine in New York, New York. Dr. George is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Shwachman-Diamond Syndrome, Familial Multiple Lipomatosis, Transient Erythroblastopenia of Childhood, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. George is currently accepting new patients.

Alice Levine is an Endocrinologist practicing medicine in New York, New York. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Cushing's syndrome, Pheochromocytoma, Adrenal Gland Adenoma, and Ectopic Cushing's syndrome.

Laura Boucai is an Endocrinologist practicing medicine in New York, New York. Dr. Boucai is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, and Thyroidectomy.

Christopher Barker is a Radiation Oncologist practicing medicine in New York, New York. Dr. Barker is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.